Navidea Biopharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John K. Scott, Jr.(61.8%)
Navidea Biopharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John K. Scott, Jr.(61.8%)
Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scott John K Jr.
Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Moss Dana J
Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Stefanelli Jill
Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-CHIEF FINANCIAL OFFICER Dais Craig
Navidea Biopharmaceuticals | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Dais Craig
Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Moss Dana J
Navidea Biopharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Moss Dana J
Navidea Biopharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John K. Scott, Jr.(75.04%)
Navidea Biopharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Irwin Bain(4.73%)
Navidea Biopharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Irwin Bain(4.73%)
Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scott John K Jr.
Navidea Biopharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John K. Scott, Jr.(52.85%)
Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scott John K Jr.
Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Stefanelli Jill
Navidea Biopharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Stefanelli Jill
Navidea Biopharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Witter Malcolm G
Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities
No Data
No Data